Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffPaysInc.i » - entrée « University »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
United Kingdom of Great Britain and Northern Ireland < University < University College London.  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
002931 (2013) J. Post Pski ; A. Poluha ; E. Olesi Ska ; P. Sikora [Pologne]THU0465 Severe Fibrodysplasia Ossificans Progressiva in a 3-Year-Old Girl with Atypical Acvr1 Mutation (G356D)
002995 (2013) E. Olesinska ; J. Postepski ; J. Tabarkiewicz ; B. Wilczynska ; E. Tuszkiewicz-Misztal [Pologne]THU0301 Neopterin (NPT) and soluble interleukin 2 receptor (SIL-2R) as useful markers of disease activity in juvenile idiopathic arthritis (JIA)
002A43 (2013) H. Yamanaka ; M. Harigai ; S. Inokuma [Japon] ; N. Ishiguro ; J. Ryu [Japon] ; S. Takei ; T. Takeuchi [Japon] ; Y. Tanaka ; Y. Sano [Japon] ; T. Koike [Japon]THU0092 The advantage of early intervention by tocilizumab for rheumatoid arthritis - full analysis of all-case postmarketing surveillance in 7,901 patients in japan
002B24 (2013) H.-H. Chen ; N. Huang ; Y.-M. Chen ; T.-J. Chen ; P. Chou ; Y.-L. Lee ; Y.-J. Chou ; J.-L. Lan ; K.-L. Lai ; C.-H. Lin [République populaire de Chine] ; D.-Y. ChenSAT0459 Significant association between periodontitis and risk of rheumatoid arthritis: A nationwide, population-based, case–control study
002B81 (2013) T. Matsutani ; M. Murakami ; M. Sekiguchi ; K. Matsui ; M. Kitano ; M. Namiki ; K. Ohmura [Japon] ; Y. Imura [Japon] ; T. Fujii [Japon] ; T. Kuroiwa ; H. Nakahara ; S. Hika ; K. Maeda ; Y. Nozaki ; M. Funauchi ; K. Murakami ; T. Ikawa ; S. Irimajiri ; A. Nampei ; T. Azuma ; T. Sasaki ; A. Yokota ; S. Morita ; Y. Kawahito ; T. Mimori [Japon] ; H. Sano ; N. Nishimoto [Japon]SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients
002C06 (2013) A. Thiolat ; J. Biton ; L. Semerano [France] ; D. Lemeiter ; M.-C. Boissier [France] ; N. BessisSAT0042 Treatment by anti-IL-6 receptor acts on CD4+ FOXP3+ regulatory t cells in a model of rheumatoid arthritis
002C07 (2013) K. Y. Kang ; Y.-K. Kim ; H. Yi ; J. Kim ; H.-R. Jung [Corée du Sud] ; I. J. Kim ; J. H. JuSAT0041 Metformin downregulates TH17 differentiation and attenuates murine autoimmune arthritis
002C87 (2013) Y. Maeda ; M. Matsushita ; A. Yura ; S. Teshigawara ; M. Katayama ; M. Yoshimura ; A. Watanabe ; E. Tanaka ; S. Tsuji ; A. Kitatobe ; Y. Harada ; S. Ohshima ; Y. Katada ; J. Hashimoto ; K. Ogata [Japon] ; T. Takahashi [Japon] ; H. Tsuji [Japon] ; K. Nomoto [Japon] ; A. Kumanogoh ; K. Takeda ; Y. SaekiOP0191 The Fecal Microbiota of Rheumatoid Arthritis Patients Differs from that of Healthy Volunteers and is Considerably Altered by Treatment with Biologics
002C95 (2013) T. Miyamae ; T. Nozawa [Japon] ; M. Kikuchi ; T. Kizawa ; T. Imagawa ; S. YokotaOP0178 Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis
002D30 (2013) T. Takeuchi [Japon] ; Y. Kaneko [Japon] ; T. Atsumi ; Y. Tanaka ; M. Inoh ; H. Kobayashi [Japon] ; K. Amano ; M. Miyata ; Y. Murakawa ; T. Fujii ; A. Kawakami ; H. Yamanaka ; K. Yamamoto ; N. Miyasaka [Japon] ; T. MimoriOP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study)
002E56 (2013) J. E. Pope ; E. Rampakakis ; J. Sampalis ; O. Desjardins [Canada]FRI0187 The effectiveness of abatacept in a large RA real world database including durability and changes in haq over time: Post DMARDs and post TNF
003004 (2013) K. Mitchell ; M. Bukhari [Royaume-Uni] ; P. DiggleAB0775 Predictors of osteopenia in a uk population referred for dexa scanning
003018 (2013) M. Can ; F. Alibaz-Öner ; B. Ilhan ; S. Öner ; N. Inanc ; T. Ergun ; G. Mumcu [Turquie] ; H. DireskeneliAB0765 Quality of life and fatigue in patients with behcet’s disease
003046 (2013) G. Cavalli ; C. Campochiaro ; A. Berti ; B. Guglielmi [Italie] ; M. G. Sabbadini [Italie] ; L. Dagna [Italie]AB0708 Efficacy of oral tacrolimus in two patients with scleritis and relapsing polychondritis
003070 (2013) Y. Tanaka ; T. Abe ; T. Takeuchi ; A. Yamamoto ; N. Miyasaka [Japon]AB0587 Safety and efficacy of abatacept(ABA) demonstrated in patients with rheumatoid arthritis(RA); 4-year data from phase III open-label, multicenter, long-term extension trial
003094 (2013) M. J. Lim ; S. H. Park [Corée du Sud] ; S.-C. Shim ; H. J. Baek ; D.-H. Yoo ; H. A. Kim ; S. K. Lee ; Y. J. Lee [Corée du Sud] ; Y. E. Park ; H.-S. Cha ; W. Park ; Y.-W. Song [Corée du Sud]AB0562 A double-blind, placebo-controlled, multicenter trial of tocilizumab in moderate to severe active RA patients with inadequate response to methotrexate in korean population
003266 (2013) A. A. Fathy ; S. M. Rashad ; Z. A. Selim ; D. M. Elsebaity [Égypte]AB0258 Cataract extraction (CE) and intraocular lens implantation (IOL) in patients with rheumatoid arthritis (RA)
003273 (2013) V. A. Malievsky ; T. V. Victorova [Russie] ; K. V. Danilko ; L. NazarovaAB0253 The association of the IL1B and TNFα gene polymorphism with juvenile arthritis
003299 (2013) J. N. Chae ; C. G. Jung ; G. Choi ; J.-S. Ha ; S.-H. Park ; Y. S. Kim ; S.-H. KimAB0051 Regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus and behcet’s disease
003623 (2012) Zhifeng Sheng ; Dejun Tong ; Yangna Ou [République populaire de Chine] ; Hongbin Zhang ; Zhimin Zhang ; Shuang Li ; Jianlin Zhou ; Jian Zhang ; Eryuan LiaoSerum sclerostin levels were positively correlated with fat mass and bone mineral density in Central South Chinese postmenopausal women
004003 (2009) Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu KishimotoEvidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffPaysInc.i -k "University" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffPaysInc.i  \
                -Sk "University" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffPaysInc.i
   |clé=    University
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021